• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Archives for September–December 2020

Serological Screening of Blood Donations Suggests SARS-CoV-2 May Have Been Introduced in the US before January 2020

The first case of SARS-Cov-2 in the United States was reported on January 19, 2020 in Washington State, but phylogenic…

December 22, 2020

CRISPR-Cas9 Gene Editing and Lentiviral Gene Therapy Hold Promise to Treat Transfusion Dependent β-Globin Hemoglobinopathies

Both transfusion-dependent β-thalassemia (TDT) and sickle cell disease (SCD) are common monogenetic diseases caused by mutations in the gene encoding…

December 15, 2020

NT-proBNP Levels May Help Diagnose TACO and TRALI

Distinguishing between transfusion-associated circulatory overload (TACO), transfusion-related acute lung injury (TRALI), and other pulmonary transfusion reactions, including transfused-associated acute respiratory…

December 9, 2020

RBC Transfusions Reduce Fatigability in Hospitalized Patients with Anemia

In order to determine if red blood cell (RBC) transfusions improve quality of life for hospitalized patients with anemia, researchers…

December 1, 2020

High Seroprevalence of SARS-CoV-2 in Kenyan Blood Donors

As of late July 2020, only 3% of recorded deaths due to COVID-19 have occurred in Africa despite being home…

November 25, 2020

FDA Issues Emergency Use Authorization for SARS-CoV-2 Monoclonal Antibody Therapy

Approximately 10% of COVID-19 cases lead to severe respiratory distress and hospitalization.  In an effort to develop specific therapeutic options…

November 17, 2020

Transfusion-Transmission of Hepatitis E from Solvent/Detergent-Treated Plasma

Scientists in France recently found evidence for possible hepatitis E virus (HEV) transmission in plasma treated with solvent/detergent from two…

November 11, 2020

Neutralizing Antibodies to SARS-CoV-2 Persist for at Least 5 Months

Since December 2019, SARS-CoV-2 has infected over 46 million individuals worldwide leading to over 1 million deaths.  While the majority…

November 3, 2020

Cochrane Living Systematic Review: More Data Needed to Determine Efficacy of COVID-19 Convalescent Plasma

Researchers from the Cochrane Library are performing monthly systematic reviews to evaluate the current data on the effectiveness of COVID-19…

October 28, 2020

No Evidence of SARS-CoV-2 Transfusion Transmission or Viral Infectivity

About 20-25% of individuals infected with SARS-CoV-2 develop severe symptoms, but many infected individuals are asymptomatic and may donate blood…

October 21, 2020

  • Page 1
  • Page 2
  • Next Page »

Primary Sidebar

Latest News

  • Directed Blood Donations Should be Limited

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley